85 related articles for article (PubMed ID: 32827589)
1. Histologic validation of auto-contoured dominant intraprostatic lesions on [
Alfano R; Bauman GS; Liu W; Thiessen JD; Rachinsky I; Pavlosky W; Butler J; Gaed M; Moussa M; Gomez JA; Chin JL; Pautler S; Ward AD
Radiother Oncol; 2020 Nov; 152():34-41. PubMed ID: 32827589
[TBL] [Abstract][Full Text] [Related]
2. [
Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
4. Short-duration dynamic [
Yang DM; Alfano R; Bauman G; Thiessen JD; Chin J; Pautler S; Moussa M; Gomez JA; Rachinsky I; Gaed M; Chung KJ; Ward A; Lee TY
EJNMMI Res; 2021 Oct; 11(1):107. PubMed ID: 34652551
[TBL] [Abstract][Full Text] [Related]
5. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
[TBL] [Abstract][Full Text] [Related]
6. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
7. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL
Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386
[TBL] [Abstract][Full Text] [Related]
8. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [
Yang DM; Li F; Bauman G; Chin J; Pautler S; Moussa M; Rachinsky I; Valliant J; Lee TY
EJNMMI Res; 2021 Jan; 11(1):2. PubMed ID: 33394284
[TBL] [Abstract][Full Text] [Related]
11. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Holzschuh JC; Mix M; Ruf J; Hölscher T; Kotzerke J; Vrachimis A; Doolan P; Ilhan H; Marinescu IM; Spohn SKB; Fechter T; Kuhn D; Bronsert P; Gratzke C; Grosu R; Kamran SC; Heidari P; Ng TSC; Könik A; Grosu AL; Zamboglou C
Radiother Oncol; 2023 Nov; 188():109774. PubMed ID: 37394103
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Rowe SP; Gage KL; Faraj SF; Macura KJ; Cornish TC; Gonzalez-Roibon N; Guner G; Munari E; Partin AW; Pavlovich CP; Han M; Carter HB; Bivalacqua TJ; Blackford A; Holt D; Dannals RF; Netto GJ; Lodge MA; Mease RC; Pomper MG; Cho SY
J Nucl Med; 2015 Jul; 56(7):1003-1010. PubMed ID: 26069305
[TBL] [Abstract][Full Text] [Related]
13. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
[TBL] [Abstract][Full Text] [Related]
14. Effect of androgen deprivation therapy on intraprostatic tumour volume identified on
Chan J; Carver A; Brunt JN; Vinjamuri S; Syndikus I
Br J Radiol; 2017 Mar; 90(1071):20160818. PubMed ID: 27993093
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour.
Gaudreault M; Chang D; Hardcastle N; Jackson P; Kron T; Hofman MS; Siva S
Clin Transl Radiat Oncol; 2022 Jul; 35():84-89. PubMed ID: 35662883
[TBL] [Abstract][Full Text] [Related]
16.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Manual and Semi-Automatic [
Spohn SKB; Kramer M; Kiefer S; Bronsert P; Sigle A; Schultze-Seemann W; Jilg CA; Sprave T; Ceci L; Fassbender TF; Nicolay NH; Ruf J; Grosu AL; Zamboglou C
Front Oncol; 2020; 10():600690. PubMed ID: 33365271
[TBL] [Abstract][Full Text] [Related]
18. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
20. Gallium-68-prostate-specific membrane antigen (
van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
